A Phase 3 Investigator-blinded, Randomized, Placebo and Active Parallel Group, non-inferiority, Multicenter study of M512101 in Japanese Patients with Acne Vulgaris

Trial Profile

A Phase 3 Investigator-blinded, Randomized, Placebo and Active Parallel Group, non-inferiority, Multicenter study of M512101 in Japanese Patients with Acne Vulgaris

Completed
Phase of Trial: Phase III

Latest Information Update: 23 May 2016

At a glance

  • Drugs Ozenoxacin (Primary) ; Nadifloxacin
  • Indications Acne vulgaris
  • Focus Therapeutic Use
  • Sponsors Maruho
  • Most Recent Events

    • 04 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top